| SUN |
MON |
TUE |
WED |
THU |
FRI |
SAT |
| |
|
|
|
|
1 |
2 |
| 3 |
4 |
5 |
6 |
7 |
8 |
9 |
| 10 |
11 |
12 |
13 |
14 |
15 |
16 |
| 17 |
18 |
19 |
20 |
21 |
22 |
23 |
| 24 |
25 |
26 |
27 |
28 |
29 |
30 |
| 31 |
|
|
|
|
|
|
♦=seminar
dates
|
| Oct.6 |
11th Kumamoto AIDS Seminar |
Oct.13
|
Chairperson:Saito
Tomohiro Akahoshi (Takiguchi Project Laboratory)
The cross-recognition of an escape mutant by HIV-1-specific cytotoxic T lymphocytes
Hiromi Aoki (Hematology)
Early Phase Dynamics of HIV Infection in hPBMC-Transplanted NOD/SCID/Jak3-/- Mice Using Infectious HIV Carrying a Fluorescent Protein, mCherry <drug's therapeutic effect > |
Oct.20
|
Chairperson:Hashimoto
Zafrul Hasan (Ueno Project Laboratory)
Implication of the effects of host immune responses on the HIV-1 vpu gene evolution
Nobuyo Kuwata (Hematology)
What we have learned from the HIVmCherry infected huPBMC transplanted NOJ mouse model |
Oct.27
|
Chairperson:Harada
Mwimanzi Philip(Ueno Project Laboratory)
Nef activity in down regulation of viral receptors and protection of HIV superinfection is modulated by Nef mutations that confer CTL escape during acute infection
Ryusho Kariya (Okada Project Laboratory)
HIV protease inhibitor inhibits the growth of Primary effusion lymphoma and induces apoptosis |
|
